{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-024304","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.303821+00:00","generated_at":"2026-05-31T13:39:14.121540+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LeMaitre Q2 EPS $0.52 +44%, FY guidance raised; dividend $0.16","bullets":["Sales $55.8M +11% (+12% organic); EPS $0.52 +44% vs Q2 2023.","Gross margin 68.9% (+490 bps); operating income $14.4M +52%.","Allografts +30%, bovine patches +12%, carotid shunts +22% led growth.","Q3 guidance: sales $52.7-54.7M, EPS $0.42-0.46; FY guidance raised to sales $218.8M, EPS $1.82-1.91.","Quarterly dividend $0.16/share payable Aug 29, record Aug 15."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-024304","json":"https://secwatch.observer/filing/0001437749-24-024304.json","markdown":"https://secwatch.observer/filing/0001437749-24-024304.md","text":"https://secwatch.observer/filing/0001437749-24-024304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/0001437749-24-024304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/lmat20240801_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:39:14.121540+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}